Skip to main content
. Author manuscript; available in PMC: 2013 May 16.
Published in final edited form as: Acta Pharm Sin B. 2012 Apr 1;2(2):213–219. doi: 10.1016/j.apsb.2012.02.008

Table 2.

Pharmacokinetic parameters of prodrugs and parent 3 in male Sprague-Dawley rats (180–200 g) by i.g. (20 mg/kg) dosing and 3 by i.v. (2 mg/kg) in 10% PEG400.

Parameter Compound 3(iv)
5 6 7 8 9 10 12 13 3
AUC(0-t) ng·L/mL 521.7 ± 133.6 157.9 ± 42.94 354.2 ± 105.6 588.9 ± 72.06 384.1 ± 6.21 1296.5 ± 437.6 775.6 ± 162.9 477.8 ± 128.7 966.3 ± 219.7 558.4 ± 8.71
CL (L/h/kg) 0.033 ± 0.006 0.102 ± 0.020 0.046 ± 0.013 0.034 ± 0.004 0.037 ± 0.001 0.016 ± 0.007 0.026 ± 0.005 0.040 ± 0.010 0.020 ± 0.005 0.003 ± 0.0001
Vd (L/kg) 0.252 ± 0.130 0.669 ± 0.422 0.373 ± 0.193 0.102 ± 0.011 0.467 ± 0.063 0.045 ± 0.017 0.049 ± 0.020 0.123 ± 0.058 0.079 ± 0.039 0.008 ± 0.002
Cmax (ng/mL) 284.1 ± 74.73 80.9 ± 18.80 254.6 ± 32.45 398.5 ± 29.00 163.6 ± 13.56 621.5 ± 79.67 529.0 ± 192.9 191.1 ± 2.48 530.7 ± 120.8
Tmax (h) 0.50 0.38 0.25 0.50 0.25 0.75 0.50 0.75 0.58
MRT(0-t) (h) 3.092 ± 0.454 2.658 ± 0.681 3.769 ± 0.063 1.517 ± 0.207 3.581 ± 0.307 1.793 ± 0.181 1.286 ± 0.085 2.136 ± 0.123 1.983 ± 0.478 1.235 ± 0.168
F(%) 10.3 3.3 7.2 12.4 7.5 25.7 15.8 9.8 17.3